Basel Medical (BMGL) Long-Term Investments (2025)

Basel Medical's (BMGL) quarterly Long-Term Investments came in at $37.64 in Q2 2025.

Basel Medical (BMGL) Long-Term Investments (2025) Analysis & Trends

Basel Medical has disclosed Long-Term Investments across 1 years of filings, most recently posting $37.64 for Q2 2025.

  • Long-Term Investments for Q2 2025 came in at $37.64, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $37.64 (changed N/A YoY), and the FY2025 annual result was $39.0, changed N/A from the prior year.
  • Long-Term Investments came in at $37.64 for Q2 2025 at Basel Medical.
  • In the past five years, Long-Term Investments ranged from a high of $37.64 in Q2 2025 to a low of $37.64 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn 387.00 Mn
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn 3.81 Bn
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn 167.44 Mn
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn -
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn -
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn -
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn 772.52 Mn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn 143.78 Mn
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn -
10 Basel Medical 8.86 Mn 6.52 Mn - 37.64

Historic Data

Download Data
DateValue
Jun 30, 2025 37.64